Is GeneDx Holdings Corp. (WGSWW) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | N/A | N/A | N/A | N/A | ? INSUFFICIENT DATA |
| DJIM | N/A | N/A | N/A | N/A | ? INSUFFICIENT DATA |
| MSCI | 21.6% / 33% | 32.7% / 33% | 14.2% / 33% | 1.29% / 5% | ✓ HALAL |
| S&P | N/A | N/A | N/A | N/A | ? INSUFFICIENT DATA |
| FTSE | 21.6% / 33% | 32.7% / 33% | 14.2% / 50% | 1.29% / 5% | ✓ HALAL |
Financial Highlights
Profitability
| Gross Margin | 69.7% | |
| Operating Margin | -10.6% | |
| Net Margin | -4.9% | |
| Return on Equity (ROE) | -7.6% | |
| Return on Assets (ROA) | -1.5% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $33M |
| Free Cash Flow | $14M |
| Total Debt | $113M |
| Debt-to-Equity | 36.7 |
| Current Ratio | 2.5 |
| Total Assets | $524M |
Price & Trading
| Last Close | $0.01 |
| Beta | 2.1 |
|
52-Week Range
$0.01
| |
About GeneDx Holdings Corp. (WGSWW)
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
Related Halal Stocks in
Frequently Asked Questions
Is GeneDx Holdings Corp. (WGSWW) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), GeneDx Holdings Corp. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is GeneDx Holdings Corp.'s debt ratio?
GeneDx Holdings Corp.'s debt ratio is not available under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 21.6%.
What are GeneDx Holdings Corp.'s key financial metrics?
GeneDx Holdings Corp. has a market capitalization of N/A, and revenue of $428M. The company maintains a gross margin of 69.7% and a net margin of -4.9%. Return on equity stands at -7.6%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.